Target intelligence / Profile preview

Pilus adhesin RrgA (RrgA)

Target
RrgA
Molecular classification
Bacterial surface protein, Adhesin, Pilus protein, Ancillary pilus subunit
01

Overview

Pilus adhesin RrgA is the primary adhesive protein located at the tip of the type 1 pilus (pilus-1) in Streptococcus pneumoniae. It mediates the initial attachment of the bacterium to host tissues by binding to respiratory epithelial cells, vascular endothelial cells, and extracellular matrix components such as collagen I, fibronectin, and laminin (PMID: 18250390, 20133637). Beyond its role in colonization, RrgA facilitates the crossing of the blood-brain barrier and interacts with host immune cells, including macrophages, through the complement receptor 3 (CR3) to modulate the inflammatory response (PMID: 23269481, 32185835). Due to its critical role in virulence and its high surface exposure, RrgA is a prominent candidate for the development of serotype-independent, protein-based pneumococcal vaccines. Therapeutic strategies targeting RrgA, such as monoclonal antibodies or vaccine-induced immunity, aim to block bacterial adherence and prevent invasive diseases like pneumonia, meningitis, and sepsis (PMID: 33141143, 20660671).

Other names
RrgA proteinPneumococcal pilus-1 adhesinAncillary pilus subunit RrgAStreptococcus pneumoniae RrgA
02

Mechanism of action

Inhibition of bacterial adherence to host cells and extracellular matrix components, thereby preventing colonization and invasive disease.

03

Biological functions

Cell adhesionHost-cell interactionBiofilm formationPhagocytosis modulationBacterial colonizationTranslocation of epithelial barriers
04

Disease associations

InfectionPneumoniaMeningitisSepsisOtitis media
05

Safety considerations

Strain replacementAntigenic variation (Clade I and II)Immune evasion
06

Interacting drugs

Experimental pneumococcal protein vaccines

1 more in the full profile.

07

Biomarkers

Pilus islet 1 (PI-1) presencerrgA gene expression

Beyond the preview

Go deeper on Pilus adhesin RrgA (RrgA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pilus adhesin RrgA (RrgA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call